PLG-0301

N/A

Report date: 2022/01/30 09:41:49
NME

Base Information

Drug NamePLG-0301
Drug Alias NamePLG-0301
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung DiseasesCystic FibrosisBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPeptilogics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeptilogics Inc
Inactive CompaniesN/A
Active IndicationsLung DiseasesCystic FibrosisBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A